Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Smyth

Showing results (291-300 of 294) with videos related to

Pageof 30
Sort By:
You have reached the last page of results.This site can display upto 294 results.
Nature Genetics|June 24, 2003
OPCML at 11q25 is epigenetically inactivated and has tumor-suppressor function in epithelial ovarian cancerGrant C Sellar, Karen P Watt, Genevieve J Rabiasz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2007
Antiestrogen therapy is active in selected ovarian cancer cases: the use of letrozole in estrogen receptor-positive patientsJohn F Smyth, Charlie Gourley, Graeme Walker, et al.
Molecular Oncology|January 23, 2016
Excellent translational research in oncology: A journey towards novel and more effective anti-cancer therapiesA Rajan, A Berns, U Ringborg, et al.
Cancer Research|November 9, 2011
A dynamic inflammatory cytokine network in the human ovarian cancer microenvironmentHagen Kulbe, Probir Chakravarty, D Andrew Leinster, et al.
Pageof 30

Showing results (291-300 of 294) with videos related to

Sort By:
Pageof 30
You have reached the last page of results.This site can display upto 294 results.
Nature Genetics|June 24, 2003
OPCML at 11q25 is epigenetically inactivated and has tumor-suppressor function in epithelial ovarian cancerGrant C Sellar, Karen P Watt, Genevieve J Rabiasz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2007
Antiestrogen therapy is active in selected ovarian cancer cases: the use of letrozole in estrogen receptor-positive patientsJohn F Smyth, Charlie Gourley, Graeme Walker, et al.
Molecular Oncology|January 23, 2016
Excellent translational research in oncology: A journey towards novel and more effective anti-cancer therapiesA Rajan, A Berns, U Ringborg, et al.
Cancer Research|November 9, 2011
A dynamic inflammatory cytokine network in the human ovarian cancer microenvironmentHagen Kulbe, Probir Chakravarty, D Andrew Leinster, et al.
Pageof 30